Next Article in Journal
The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension
Next Article in Special Issue
Oromucosal Administration of Interferon to Humans
Previous Article in Journal
Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
Pharmaceuticals 2009, 2(3), 206-216; doi:10.3390/ph2030206
Review

Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon

*  and
Department of Pathology, F. Edward H├ębert School of Medicine, USUHS/4301 Jones Bridge Rd, Bethesda, MD 20814, USA
* Author to whom correspondence should be addressed.
Received: 13 November 2009 / Revised: 2 December 2009 / Accepted: 7 December 2009 / Published: 15 December 2009
(This article belongs to the Special Issue Interferons)
View Full-Text   |   Download PDF [164 KB, uploaded 15 December 2009]

Abstract

For more than 20 years after the excitement engendered by their discovery in 1957 as antiviral agents, there were no significant clinical uses of interferons; however, following their cloning they have been employed as effective treatment for several viral, autoimmune, and neoplastic diseases.
Keywords: interferon; clinical applications; cancer; infectious diseases; multiple sclerosis interferon; clinical applications; cancer; infectious diseases; multiple sclerosis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Export to BibTeX |
EndNote


MDPI and ACS Style

Friedman, R.M.; Contente, S. Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon. Pharmaceuticals 2009, 2, 206-216.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert